Leadership Overview
Granules has 6 executives leading key functions including operations, finance, strategic planning, human resources, formulation manufacturing, and portfolio management.
Focused on delivering high-quality pharmaceutical solutions, Granules maintains a commitment to customer-centric manufacturing of API, FD, PFI, and specialty products across global markets.
Focused on delivering high-quality pharmaceutical solutions, Granules maintains a commitment to customer-centric manufacturing of API, FD, PFI, and specialty products across global markets.
Leadership Roles at Granules
Mukesh Surana - Global Chief Financial Officer
Mukesh Surana, the Global Chief Financial Officer at Granules, manages the financial health and capital allocation strategies for the entire organization. Overseeing global fiscal planning, the Global Chief Financial Officer ensures that investment in API and specialty product development remains aligned with long-term profitability goals. This leadership role involves rigorous oversight of financial reporting, risk management, and investor relations. By maintaining a robust balance sheet, Mukesh Surana directly impacts the company's capacity for expansion and innovation. Surana coordinates with the Board to evaluate market opportunities and financial performance metrics across diverse regions. Through disciplined capital management, the Global Chief Financial Officer supports the company's growth trajectory and market competitiveness. Ultimately, Surana secures the financial foundation necessary for the firm to continue delivering high-quality pharmaceutical products while maximizing shareholder value in a complex, high-growth industry environment.
Jai Velusamy - Chief Operating Officer
Jai Velusamy, the Chief Operating Officer at Granules, directs all internal manufacturing processes and supply chain logistics. Overseeing the production of high-quality API and finished dosages, the Chief Operating Officer ensures operational excellence across all facilities. This leadership role involves optimizing manufacturing workflows to meet rigorous global pharmaceutical standards. By streamlining production cycles, Jai Velusamy directly impacts the company's ability to scale output efficiently. Velusamy manages cross-functional teams to maintain consistent product quality while driving cost-effective manufacturing strategies. Through the implementation of advanced process controls, the Chief Operating Officer supports the broader mission of delivering reliable pharmaceutical products to international markets. Ultimately, Velusamy secures the operational stability required for sustained growth in the competitive pharmaceutical sector, ensuring that manufacturing capabilities align perfectly with the evolving demands of the global healthcare industry.
Vinod Parur - President & Chief Human Resources Officer
Vinod Parur, the President & Chief Human Resources Officer at Granules, directs talent acquisition, organizational development, and employee engagement strategies. Overseeing the cultivation of a high-performance culture, the President & Chief Human Resources Officer ensures that the workforce possesses the technical expertise required for complex pharmaceutical manufacturing. This leadership role involves designing compensation structures and training programs that attract top-tier industry talent. By fostering a culture of innovation and accountability, Vinod Parur directly impacts the company's ability to maintain high-quality production standards. Parur collaborates with other executives to align human capital strategies with the firm's long-term growth objectives. Through the implementation of robust talent management systems, the President & Chief Human Resources Officer supports the company's commitment to customer-centricity. Ultimately, Parur secures the human infrastructure necessary for the organization to thrive in the global pharmaceutical market.
Ramraj Rangarajalu - President, Formulation Operations (India)
Ramraj Rangarajalu, the President, Formulation Operations (India) at Granules, manages the manufacturing of finished dosages and pharmaceutical formulations within the domestic market. Overseeing the production facilities, the President, Formulation Operations (India) ensures that all processes adhere to stringent quality and safety regulations. This leadership role involves scaling formulation capacity to meet the rising demand for high-quality pharmaceutical products. By optimizing local manufacturing operations, Ramraj Rangarajalu directly impacts the company's market presence and supply reliability. Rangarajalu coordinates with technical teams to integrate new product formulations into the existing manufacturing pipeline. Through the continuous improvement of formulation techniques, the President, Formulation Operations (India) supports the company's mission of delivering accessible healthcare solutions. Ultimately, Rangarajalu secures the operational excellence required to maintain a competitive edge in the Indian pharmaceutical sector while supporting broader international growth initiatives.
Vijay Raghavan - Global President, Portfolio
Vijay Raghavan, the Global President, Portfolio at Granules, directs the development and management of the company's diverse pharmaceutical product pipeline. Overseeing the strategic selection of API and specialty products, the Global President, Portfolio ensures that the product mix aligns with global market trends and customer needs. This leadership role involves analyzing market data to identify high-growth opportunities and prioritizing research and development efforts. By curating a robust portfolio, Vijay Raghavan directly impacts the company's revenue growth and market positioning. Raghavan collaborates with the manufacturing and finance teams to ensure that new products move efficiently from development to commercialization. Through the strategic expansion of the product range, the Global President, Portfolio supports the company's commitment to delivering high-quality pharmaceutical solutions. Ultimately, Raghavan secures the long-term viability of the product pipeline, ensuring the firm remains at the forefront of the pharmaceutical industry.
Sriram Chavali - EA-Chief of Staff, Directorate
Sriram Chavali, the EA-Chief of Staff, Directorate at Granules, coordinates strategic initiatives and facilitates communication across the executive leadership team. Overseeing the execution of corporate priorities, the EA-Chief of Staff, Directorate ensures that departmental goals remain synchronized with the overarching mission of the company. This leadership role involves managing complex projects and streamlining decision-making processes to enhance organizational agility. By bridging the gap between the directorate and operational units, Sriram Chavali directly impacts the efficiency of strategic implementation. Chavali monitors progress on key business objectives and provides critical insights to support executive decision-making. Through the alignment of internal resources, the EA-Chief of Staff, Directorate supports the company's focus on customer-centric pharmaceutical manufacturing. Ultimately, Chavali secures the operational cohesion required to drive the firm's growth and maintain its position as a leader in the pharmaceutical manufacturing landscape.
Explore Leadership Teams in Manufacturing
Bayer is a global enterprise with core competencies in the life science fields of health care and agriculture, headquartered in Leverkusen, Germany. The company operates through three divisions: Pharmaceuticals, which focuses on prescription products for cardiology, women's health, oncology, hematology, and ophthalmology; Consumer Health, a supplier of self-care products across dermatology, nutrition, and pain management; and Crop Science, which provides seeds, biotechnology traits, and crop protection products. Bayer serves patients, consumers, and farmers globally, delivering value through a combination of innovative medicines, self-care brands, and digital farming tools designed to improve human health and support sustainable food security.
Company Leadership DB
LS
ES
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.
Company Leadership ES
NB
Jazz Pharmaceuticals plc is a global biopharmaceutical company headquartered in Dublin, Ireland, founded in 2003. The company develops and commercializes medicines for serious diseases with limited treatment options, focusing on neuroscience, including sleep medicine and movement disorders, and oncology, including hematologic malignancies and solid tumors. Jazz maintains a global presence with offices and manufacturing facilities across the U.S., UK, Ireland, and Italy and advances its portfolio through internal R&D, acquisitions, and licensing partnerships.
Company Leadership
JU
RI
Columbia Care is a multi-state medical cannabis cultivator, manufacturer and provider of cannabis products and related services. Columbia Care is headquartered in New York, New York.
Company Leadership KR
ST
DH
Frequently Asked Questions Regarding Granules Top Executives and Leadership Team
